Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by SELLAS Life Sciences Group, Inc. on June 8, 2021. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol SLS.
Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a current report regarding corporate governance events rather than a financial statement.
Material Changes
There are no material financial changes reported in this filing. The primary event is the completion of the Annual Meeting where stockholders voted on four proposals. Approximately 53.02% of all outstanding shares (7,997,810 shares) were present in person or by proxy.
Outlook, Risks, and Voting Results
The filing details the outcomes of four stockholder proposals:
- Proposal 1 (Director Election): David Scheinberg was re-elected as a Class II director. Votes cast: 2,994,106 For, 439,536 Withheld, 4,564,168 Broker Non-Votes.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of Moss Adams LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021. Votes cast: 7,732,871 For, 201,572 Against, 63,367 Abstain.
- Proposal 3 (Executive Compensation): The non-binding advisory resolution on executive compensation was approved. Votes cast: 2,383,795 For, 849,429 Against, 200,418 Abstain, 4,564,168 Broker Non-Votes.
- Proposal 4 (Employee Stock Purchase Plan): The 2021 Employee Stock Purchase Plan was approved. Votes cast: 2,808,810 For, 481,196 Against, 143,636 Abstain, 4,564,168 Broker Non-Votes.
No other matters were submitted to a vote, and the filing does not provide specific management commentary on future outlook, risks, or contingencies beyond the standard governance disclosures.
Key Facts for Investors
- The Annual Meeting was held on June 8, 2021, with 53.02% shareholder participation.
- All four proposals submitted to stockholders were approved.
- Moss Adams LLP was ratified as the independent auditor for the 2021 fiscal year.
- David Scheinberg was re-elected to the Board of Directors.
- This filing contains no financial data; investors should refer to the company's 10-K or 10-Q filings for financial metrics.